Video Latest - ecancer

Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions

Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA

29 Apr 2016

Drugging “undruggable” transcription factor drivers in cancer

Dr John Bushweller - Unviersity of Virgina, Virginia, USA

28 Apr 2016

Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA

28 Apr 2016

Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA

28 Apr 2016

Elucidation and pharmacological targeting of tumour checkpoint dependencies

Dr Andrea Califano - Colombia University Medical Centre, New York, USA

28 Apr 2016

New technology can potentially overcome CAR T-cell limitations

Dr Philip Low - Purdue University, West Lafayette, USA

27 Apr 2016

AML17 Trial results: maximum dosage of daunorubicin in AML

Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK

27 Apr 2016

AML during pregancy

Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK

27 Apr 2016

Germ line predisposition to leukaemia

Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA

27 Apr 2016

The future of haematopathology

Prof Alberto Zamo - University of Verona, Verona, Italy

27 Apr 2016

Genomics of childhood ALL

Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel

27 Apr 2016

Cell of origin role in cancer stem cell and GBM phenotype

Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA

27 Apr 2016

Video